Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
A biosensor is a biological detection system consists of a biological component combined with a transducer to perform measurement of a biochemical quantity. A typical biosensor includes a bio element such as an enzyme, antibody, or a cell receptor, and a sensing element or a transducer. Biosensors are nowadays ubiquitous in biomedical diagnosis as well as a wide range of other areas such as point-of-care monitoring of treatment and disease progression etc. This has led to the rapid adoption of biosensors in various applications including Point of care, home diagnostics, research labs, biodefence, environmental monitoring and food and beverages. The advancement in the field of nanotechnology, has facilitated the innovation of advanced products like noninvasive biosensors in the market. This has created numerous opportunities for new as well as existing players in the market.
There are many factors which are driving the biosensors market like increasing prevalence of diabetes, Technological advancements in biosensors technology, rising requirement for point-of-care and home care devices, the emergence of nano-biosensors/nanotechnology, and extensive use of biosensor in various applications such as medical science. Moreover, growing awareness concerning maintenance of balanced and healthy lifestyle is boosting demand for wearable biosensors. These wearable biosensors enables a person to monitor various health parameters such as pulse rate, blood pressure, heartbeats and others.
As modern lifestyle encourages independence, the manner in which individuals use meds additionally gets influenced. Self-management of diabetes facilitates amalgamation of advanced technology in the glucometers, thereby driving market growth. According to International Diabetes Federation and World Health Organization, there are around 425 million people with diabetes globally, and this number is expected to rise to around 629 million globally. This high prevalence is expected to act as a major driver for the market growth owing to the preference for such technology and availability of variant diabetic biosensors in the market.
The report analyses the Biosensors Market based on product, technology, application and geography.
The various products of biosensors studies in this report include wearable biosensors and non-wearable biosensors. Wearable Biosensors are digital devices that can be worn on the body in the form of wearable systems or devices such as wristwear, eyewear, footwear, neckwear and bodywear etc. allowing blood glucose levels, blood pressure, heart beat rate and other biometric. Wearable Biosensors are gaining huge interest nowadays and at present they promise to be one of the great developments in the sector of wearable health technology. Wearable biosensors a main category of biosensors have wide application in healthcare, applications related to sports, military etc. Rapid growths of these devices are on the way which will help to provide advantages like easy to use, low cost and providing real time information.
Depending on the technology, biosensors are classified as Electrochemical Biosensors (Amperometric Sensor, Potentiometric Sensors and Conductometric Sensors), Optical Biosensors (Spr (surface plasmon resonance, Colorimetric Biosensors, Fluorescence Biosensors), Piezoelectric Biosensors (Acoustic Biosensors, Microcantilever Biosensors), Thermal Biosensors, Nanomechanical Biosensors etc. Electrochemical biosensors currently dominate the biosensing field with the most common approaches including amperometric, potentiometric, conductometric and impedimetric techniques. Electrochemical biosensors offers various advantages for example wide linear response range, low detection limits, reproducibility, and optimum stability, which lead to their greater usage as compared to other biosensing technologies.
Biosensors finds application in POC (glucose monitoring, cardiac marker, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas & electrolyte detection, tumor or cancer marker, urinalysis testing and cholesterol testing), home diagnostics (glucose monitoring, pregnancy testing and cholesterol testing) , research lab, biodefense, environmental monitoring, food & beverages. Biosensors have wide application in point of care. POC biosensors allow for the sensitive, selective, and rapid detection of diseases while remaining inexpensive. These are considered as essential tool in the detection and monitoring of a wide range of medical conditions from diabetes to cancer.
By geography, the Biosensors market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa North America is anticipated to be the dominant region in the global biosensors market due to the wide usage of them in different applications
Asia pacific is anticipated to exhibit the fastest growth during the forecast period. Presence of high unmet medical needs pertaining to target disease segments, such as cancer, diabetes and other infectious diseases, growing patient awareness levels, and constantly improving healthcare expenditure in the region, are some of the key factors attributing to growth of the market in this region.
Some of the major players opening in this region include Abbott Laboratories Inc.,F.Hoffman-La Roche, Medtronic, Universal Biosensors, Siemens AG, Lifescan, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Dowdupont Inc., Sysmex Corporation, Biacore, Biosensors International Pte. Ltd., Ercon Inc., Lifesensors, Nova Biomedical, Acon Laboratories, Inc. and Pharmaco-Kinesis Corporation among others
The report analyses the Biosensors Market based on product, technology, application and geography.
The various products of biosensors studies in this report include wearable biosensors and non-wearable biosensors. Depending on the technology, biosensors are classified as Electrochemical Biosensors (Amperometric Sensor, Potentiometric Sensors and Conductometric Sensors), Optical Biosensors (Spr (surface plasmon resonance, Colorimetric Biosensors, Fluorescence Biosensors), Piezoelectric Biosensors (Acoustic Biosensors, Microcantilever Biosensors), Thermal Biosensors, Nanomechanical Biosensors etc.
Biosensors finds application in POC (glucose monitoring, cardiac marker, infectious disease detection, coagulation monitoring, pregnancy testing, blood gas & electrolyte detection, tumor or cancer marker, urinalysis testing and cholesterol testing), home diagnostics (glucose monitoring, pregnancy testing and cholesterol testing) , research lab, biodefense, environmental monitoring, food & beverages.
By geography, the Biosensors market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa
Some of the major players opening in this region include Abbott Laboratories Inc.,F.Hoffman-La Roche, Medtronic, Universal Biosensors, Siemens AG, Lifescan, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Dowdupont Inc., Sysmex Corporation, Biacore, Biosensors International Pte. Ltd., Ercon Inc., Lifesensors, Nova Biomedical, Acon Laboratories, Inc. and Pharmaco-Kinesis Corporation among others
Why to Buy This Report:
